Newest Patent awarded from my @MIT PostDoc!
“Fluorescence-Based Detection of Protein Aggregation and Fiber Optic-Based Benchtop Instrument”
Congrats! Michael Strano, Daichi Kozawa, Xun Gong, Daniel Salem, Sooyeon Cho, Freddy Nguyen!
#science#engineering#research#innovation
.@AmericanCancer BrightEdge Entrepreneurs 2026 Showcase & Networking Reception, Cambridge: a fireside with Mark Goldsmith of @RevMedicines and Farnaz Bakhshi, remarks from CEO Shane Jacobson, and a room full of founders and mentors. #BrightEdge#cancer
As a BrightEdge alum, Nine Diagnostics gained invaluable community and insights from mentors and peers who kept the team moving forward for patients. Thank you Dawn Mattoon, Theresa Tribble and Pahini Pandya. #oncology
Some of the most important signals are hidden in plain sight. They have to be probed, discovered, and understood.
Joseph Cohen's To Be Here opens tonight at Friedrichs Pontone in Tribeca, 6 to 8 PM, 273 Church St. On view through Nov 14. #ArtAndSciencefriedrichspontone.com/exhibi…
Joseph has collaborated for over a decade with Dan Heller at @MSKCancerCenter, our co-founder and CSO at @NineDiagnostics. Carbon nanotubes in paint led to a Nature Communications paper. Nanotube sensing is our platform's foundation.
His paintings emit light beyond human vision. Our nanosensor arrays read signals that were hidden from us until now, and machine learning builds the multiomic fingerprint from a #liquidbiopsy. Joseph makes the unseen visible in paint. We make it readable.
mskcc.org/event/to-be-here
The same spirit drives us to build together across MIT where we've been doing the #research and problem-solving for medicine, industry, and government. Some of it spins into companies, some becomes the paper that changes a field, some shapes policy at scale.
Our CNT nanosensor platform reads proteomic and metabolomic signal. Algorithms combine that with clinical and contextual data. Run them separately, sensitivity and specificity are nowhere near combined. Patients aren't their singular disease.
Cycle time in cancer care is also a clinical trial problem. Faster readouts shorten trials and sharpen patient stratification. We also got into where #explainableAI bottoms out and why more data isn't better data. Episode: piped.video/watch?v=zDwKzaIi…
Twenty-some years ago there was no national home for #physicianscientist trainees. So we built one: @A_P_S_A.
Six weeks ago I judged the inaugural APSA 3MT. Fifteen students. Newest #science. The next generation doing exactly what this #community was built to produce.
Say yes to the opportunities around you.
I spent earlier this week at the 2026 @theNAMedicine Emerging Leaders Forum in D.C. As a #physicianscientist building a #diagnostics company, days like this sharpen the thinking. 🧵
I’ve lived that same instinct across my career. MD + PhD. Founding @A_P_S_A.
Moving between #medicine, #research, #academia, & company building.
The door between academia, industry, & govt is more open than most assume.
Say yes. Fail fast. Surround yourself w/ smarter people.
Fireside with @VictorDzau and Monica Bertagnolli - @theNAMedicine
Excellence comes from everywhere — build conditions for it and embrace it.
Start new collaborations from a blank page. Leave old anchors and constructs behind.